Novavax News | finanzen.ch

Kurse + Charts + Realtime		News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Orderbuch			Analysen
Historisch

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Strukturierte Produkte

Aktion

Portfolio

Watchlist

05.08.21	Novavax Reports Second Quarter 2021 Financial Results and Operational Highlights (PR Newswire)
05.08.21	Novavax Announces COVID-19 Vaccine Booster Data Demonstrating Four-Fold Increase in Neutralizing Antibody Levels Versus Peak Responses After Primary Vaccination (PR Newswire)
05.08.21	Novavax Announces COVID-19 Vaccine Booster Data Demonstrating Four-Fold Increase in Neutralizing Antibody Levels Versus Peak Responses After Primary Vaccination (PR Newswire)
05.08.21	Novavax Announces COVID-19 Vaccine Booster Data Demonstrating Four-Fold Increase in Neutralizing Antibody Levels Versus Peak Responses After Primary Vaccination (PR Newswire)
05.08.21	Novavax and Serum Institute of India Announce Submission to Regulatory Agencies in India, Indonesia, Philippines for Emergency Use Authorization of Novavax' Recombinant Nanoparticle COVID-19 Vaccine (PR Newswire)
05.08.21	Novavax and Serum Institute of India Announce Submission to Regulatory Agencies in India, Indonesia, Philippines for Emergency Use Authorization of Novavax' Recombinant Nanoparticle COVID-19 Vaccine (PR Newswire)
05.08.21	Novavax and Serum Institute of India Announce Submission to Regulatory Agencies in India, Indonesia, Philippines for Emergency Use Authorization of Novavax' Recombinant Nanoparticle COVID-19 Vaccine (PR Newswire)
05.08.21	Novavax und die Europäische Kommission schliessen einen Vorabkaufvertrag über bis zu 200 Millionen Dosen des Impfstoffs gegen COVID-19 ab (PR Newswire)
04.08.21	Novavax Says European Commission Finalizes Purchase Deal For Up To 200 Mln Doses Of COVID-19 Vaccine (RTTNews)
04.08.21	Novavax and European Commission Finalize Advance Purchase Agreement for up to 200 million doses of COVID-19 Vaccine (PR Newswire)
04.08.21	Novavax and European Commission Finalize Advance Purchase Agreement for up to 200 million doses of COVID-19 Vaccine (PR Newswire)
04.08.21	Novavax and European Commission Finalize Advance Purchase Agreement for up to 200 million doses of COVID-19 Vaccine (PR Newswire)
04.08.21	Novavax and European Commission Finalize Advance Purchase Agreement for up to 200 million doses of COVID-19 Vaccine (PR Newswire)
06.07.21	Novavax to Host Conference Call to Discuss Second Quarter Financial Results and Operational Highlights on August 5, 2021 (PR Newswire)
30.06.21	Novavax Publishes Results of United Kingdom Phase 3 Clinical Trial in New England Journal of Medicine, Demonstrating High Levels of Efficacy of COVID-19 Vaccine (PR Newswire)
30.06.21	Novavax Publishes Results of United Kingdom Phase 3 Clinical Trial in New England Journal of Medicine, Demonstrating High Levels of Efficacy of COVID-19 Vaccine (PR Newswire)
17.06.21	Novavax to Participate in Fireside Chat at SVB Leerink CybeRx Series: Vaccine Forum (PR Newswire)
17.06.21	Novavax to Participate in National Vaccine Advisory Committee Meeting (PR Newswire)
16.06.21	Le vaccin Novavax contre la COVID-19 démontre une efficacité globale de 90 % et une protection complète contre les formes modérées et graves de la maladie dans l'étude de phase 3 PREVENT-19 (PR Newswire)
15.06.21	Le vaccin de Novavax contre la COVID-19 démontre une efficacité globale de 90 % et une protection de 100 % contre les formes modérées et graves de la maladie durant l'essai de phase 3 PREVENT-19 (PR Newswire)
15.06.21	PREVENT-19-Phase-III-Studie: Der COVID-19-Impfstoff von Novavax zeigt eine Gesamtwirksamkeit von 90 % und einen 100 %igen Schutz vor mittelschweren und schweren Krankheitsverläufen (PR Newswire)
15.06.21	Novavax COVID-19 Vaccine Demonstrates 90% Overall Efficacy and 100% Protection Against Moderate and Severe Disease in PREVENT-19 Phase 3 Trial (PR Newswire)
14.06.21	Novavax Reports Positive Results From Study Of Influenza, COVID-19 Vaccine Administered Together (RTTNews)
14.06.21	Novavax Announces Positive Results from First Study of Influenza Vaccine and COVID-19 Vaccine Candidate Administered Simultaneously (PR Newswire)
14.06.21	Novavax Announces Positive Results from First Study of Influenza Vaccine and COVID-19 Vaccine Candidate Administered Simultaneously (PR Newswire)
14.06.21	Novavax Covid-19 Vaccine Demonstrates 90% Overall Efficacy In Phase III Study (RTTNews)
14.06.21	Novavax Says Its Covid Vaccine More Than 90% Effective (RTTNews)
14.06.21	Novavax COVID-19 Vaccine Demonstrates 90% Overall Efficacy and 100% Protection Against Moderate and Severe Disease in PREVENT-19 Phase 3 Trial (PR Newswire)
14.06.21	Novavax COVID-19 Vaccine Demonstrates 90% Overall Efficacy and 100% Protection Against Moderate and Severe Disease in PREVENT-19 Phase 3 Trial (PR Newswire)
14.06.21	Novavax COVID-19 Vaccine Demonstrates 90% Overall Efficacy and 100% Protection Against Moderate and Severe Disease in PREVENT-19 Phase 3 Trial (PR Newswire)
11.06.21	Novavax Announces Positive Data from Three Complementary Studies of COVID-19 Beta (B.1.351) Variant Strain Vaccine (PR Newswire)
09.06.21	Novavax to Host Maryland Governor Larry Hogan at Site of Future Novavax Vaccines Innovation Campus and Global Headquarters (PR Newswire)
07.06.21	Novavax to Participate in Panel at BIO Digital 2021 (PR Newswire)
24.05.21	Novavax, SK Bioscience Agree To Potentially Explore Development Of New Vaccine Products (RTTNews)
10.05.21	Novavax Report Positive Preclinical Data For NanoFlu/NVX-CoV2373 Vaccine Candidate Combination (RTTNews)
06.05.21	Novavax, Gavi Ink Advance Purchase Deal For COVID-19 Vaccine For COVAX Facility - Quick Facts (RTTNews)
03.05.21	Novavax Initiates Pediatric Expansion For Late-stage Trial Of COVID-19 Vaccine (RTTNews)
14.04.21	Novavax CFO Greg Covino To Step Down; Appoints John Trizzino As Interim CFO (RTTNews)
05.04.21	Novavax Initiates COVID-19 Vaccine Clinical Trial Crossover (RTTNews)
01.03.21	EARNINGS SUMMARY: Details of Novavax Inc. Q4 Earnings Report (RTTNews)
24.02.21	Takeda Updates On Phase 1/2 Trials Of Novavax And Moderna's COVID-19 Vaccine Candidates In Japan (RTTNews)
04.02.21	Switzerland To Purchase Six Mln Doses Of Novavax COVID-19 Vaccine (RTTNews)
31.01.21	Week Ahead In Pharma: Data Readouts Of COVID-19 Trials & FDA Decisions (RTTNews)
30.01.21	Novavax Does It Again! (RTTNews)
29.01.21	NVAX's Covid Jab Shows 89.3% Efficacy In UK Trial, AZRX Awaits Data, FDA Lifts Hold On BLCM Trial (RTTNews)
28.01.21	Novavax COVID-19 Vaccine 89.3% Effective In Phase 3 UK Trial (RTTNews)
08.01.21	Novavax Finalizes Deal With Australia For 51 Mln Doses Of COVID-19 Vaccine (RTTNews)

Newssuche

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Part Grp Hldg	1’263.50	2.89 %	K V
Sonova Hldg	312.10	2.66 %	K V
Novartis	93.68	2.32 %	K V
Geberit	526.80	1.97 %	K V
Roche Hldg G	254.30	1.27 %	K V
Kuehne+Nagel Int	209.50	0.72 %	K V
UBS Group	28.30	0.57 %	K V
Givaudan	3’933.00	0.36 %	K V
Nestle	76.00	0.05 %	K V
Lonza Grp	521.40	-0.04 %	K V

mehr

22.11.24		Dow Jones aktuell: Dow Jones zum Ende des Freitagshandels in der Gewinnzone
22.11.24		S&P 500-Handel aktuell: S&P 500 liegt letztendlich im Plus
22.11.24		Freundlicher Handel: NASDAQ 100 verbucht zum Ende des Freitagshandels Zuschläge
22.11.24		Freundlicher Handel in New York: Dow Jones präsentiert sich am Freitagnachmittag fester
22.11.24		Gewinne in New York: NASDAQ 100 präsentiert sich fester
22.11.24		Gute Stimmung in New York: nachmittags Pluszeichen im S&P 500
22.11.24		Starker Wochentag in New York: S&P 500 zeigt sich am Mittag fester
22.11.24		Börse New York in Grün: Dow Jones bewegt sich am Mittag im Plus